Prof. Ignatius Ou Sai Hong, Dr. James Suh, Dr. Wong Seng Weng, Dr. Amit Verma, 20170514091000
As targeted cancer therapy options are increasing, it is becoming more important to choose the most appropriate treatment for patients with cancer. At a Roche-sponsored symposium held during the 2nd ESMO Asia Congress in Singapore, four experts discussed the potential of comprehensive genomic profiling (CGP) for personalizing cancer care and helping healthcare professionals to make the best treatment decisions for individual patients.
Idiopathic pulmonary fibrosis (IPF) is a disease marked by scarring and hardening of lung tissues. As a result, the lungs are unable to take in oxygen normally, which leads to lack of oxygen in the bloodstream, causing functional impairment and disability.1 Respiratory medicine experts, Professor Dr Paul W. Noble and Professor Dr Liam Chong Kin recently spoke to MIMS Doctor on IPF diagnosis and treatment. Here are the highlights from the interview.
At the recent Asia Pacific Alliance for the Control of Influenza (APACI) workshop in Kuala Lumpur, MIMS Doctor had the privilege of having an exclusive interview with eminent paediatric infectious disease specialist, Associate Professor Tawee Chotpitayasunondh. This article captures the highlights from our conversation with him.
Asthma is a common condition prevalent in all countries of the world. To some it represents a minor, short-lived cough occurring after a viral infection; to others it is an incapacitating disease giving rise not just to morbidity but also premature death. This heterogeneity can lead to a sense of complacency and there is a need for a much improved approach to asthma to reduce unnecessary suffering. MIMS Doctor spoke to Professor Martyn Partridge who outlined a newer, more aggressive approach in asthma management.
The Asia Pacific Alliance for the Control of Influenza (APACI) recently organized an influenza workshop in Kuala Lumpur. The workshop saw eminent speakers from seven countries presenting on topics concerning the impact of influenza, vaccination of various populations, current and upcoming treatments for influenza, policy considerations and approaches for pandemic preparedness. Read about highlights from the workshop in this newsletter.
New-generation therapies targeted toward specific genetic alterations such as EGFR and ALK mutations in non-small cell lung cancer (NSCLC) can overcome resistance to first-generation therapies and improve survival of patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.
At the recent Infectious Disease Symposium held on the 5th of August 2016, at Le Meridien Kuala Lumpur, two speakers spoke on the role of macrolides in the management of respiratory tract infections, as well as the importance of antibiotic stewardship in combating microbial resistance.
Tiotropium Respimat is superior over Handihaler in improving time of sleep spent with sleeping oxygen saturation below 90 (TST90) and sleep parameters in patients with chronic obstructive pulmonary disease (COPD) as performed in a randomised, open-label, parallel group trial.